We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CHOLAHLDNG:NSECholamandalam Financial Holdings Ltd Analysis

Data as of 2026-03-15 - not real-time

₹1,553.90

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Cholamandalam Financial Holdings is trading at ₹1,554, comfortably below its 20‑day (₹1,643), 50‑day (₹1,707) and 200‑day (₹1,865) simple moving averages, indicating a short‑term bearish bias. The RSI sits around 40 and the MACD line is under the signal, reinforcing the downside momentum, while volatility is elevated at roughly 38% and beta is near zero, suggesting the stock moves independently of broader market swings. Support is anchored near ₹1,451 with resistance around ₹1,779, and volume has been picking up, hinting at potential further testing of the support zone.
Fundamentally, the company shows robust top‑line strength with revenue growth of about 19% and high gross (≈75%) and operating (≈35%) margins. Its trailing P/E of 12.3 is well below the industry average of 16.4, and analyst targets imply a 38% upside, while the dividend payout is minimal but clearly sustainable (payout ratio ~1%). However, the balance sheet is heavily leveraged (debt‑to‑equity > 600) despite sizable cash reserves, and the recent premium‑income surge (₹2,067 cr in Q3 FY26) is a bright spot that could fuel future earnings growth.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 4/10

Key Factors

  • Price below key moving averages and bearish MACD
  • High short‑term volatility and proximity to support level
  • Elevated leverage raising downside risk

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong revenue growth and high profitability margins
  • Undervalued valuation relative to peers with ~38% upside potential
  • Positive premium‑income trends and improving earnings outlook

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Durable credit‑services franchise with expanding loan book
  • Sustainable dividend policy despite low yield
  • Low market beta and favorable macro‑economic tailwinds for financial services

Key Metrics & Analysis

Financial Health

Revenue Growth18.60%
Profit Margin11.62%
P/E Ratio12.3
Debt/Equity635.38
P/B Ratio2.1
Industry P/E16.4

Technical Analysis

TrendBearish
RSI40.1
Support₹1,451.40
Resistance₹1,778.50
MA 20₹1,642.97
MA 50₹1,706.72
MA 200₹1,865.04
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Target Price₹2,146.67
Upside/Downside38.15%
GradeUndervalued
TypeBlend
Dividend Yield0.08%

Risk Assessment

Beta0.01
Volatility38.55%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.